- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Algorae Pharmaceuticals Ltd (1AI)
Algorae Pharmaceuticals Ltd stock price live, this page displays ASX 1AI stock exchange data. View the 1AI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Algorae Pharmaceuticals Ltd real time stock price chart below.
What Is the Algorae Pharmaceuticals Ltd Stock Price Today?
The Algorae Pharmaceuticals Ltd stock price today is 0.009.
What Is the Stock Symbol for Algorae Pharmaceuticals Ltd?
The stock symbol for Algorae Pharmaceuticals Ltd is ""1AI.""
What Stock Exchange Does Algorae Pharmaceuticals Ltd Trade On?
Algorae Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Algorae Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Algorae Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1AI quote. (ISIN: AU0000296022)
What Is the Algorae Pharmaceuticals Ltd Stock Price Today?
The Algorae Pharmaceuticals Ltd stock price today is 0.009.
What Is the Stock Symbol for Algorae Pharmaceuticals Ltd?
The stock symbol for Algorae Pharmaceuticals Ltd is ""1AI.""
What Stock Exchange Does Algorae Pharmaceuticals Ltd Trade On?
Algorae Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Algorae Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Algorae Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1AI quote. (ISIN: AU0000296022)
0.009
-0.001(-10.00%)
Closed·
Fair Value
An estimate of a Algorae Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.009
0.011
52 wk Range
0.005
0.011
1AI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week High
1/2
Fair Value
An estimate of a Algorae Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0090.011
52 wk Range
0.0050.011
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1AI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Algorae Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Algorae Pharmaceuticals Ltd Company Profile
Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer’s disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient for the treatment of cardiovascular disease, such as hypertension; and NTCELL, an alginate coated capsule product for the treatment of Parkinson’s disease. It is also developing AlgaraeOS in partnership with the University of New South Wales, a drug discovery platform that uses artificial intelligence protocols and big data analytics for drug discovery and development. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia.
Compare 1AI to Peers and Sector
Metrics to compare | 1AI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1AIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −21.0x | −6.0x | −0.7x | |
PEG Ratio | −0.31 | −0.13 | 0.00 | |
Price/Book | 7.6x | 4.7x | 2.6x | |
Price / LTM Sales | - | 10.8x | 3.4x | |
Upside (Analyst Target) | - | 216.4% | 34.9% | |
Fair Value Upside | Unlock | −3.2% | 3.1% | Unlock |
Earnings
Latest Release
Aug 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Algorae Pharmaceuticals Trade On?
Algorae Pharmaceuticals is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Algorae Pharmaceuticals?
The stock symbol for Algorae Pharmaceuticals is "1AI."
What Is the Algorae Pharmaceuticals Market Cap?
As of today, Algorae Pharmaceuticals market cap is 16.87M.
What Is Algorae Pharmaceuticals's Earnings Per Share (TTM)?
The Algorae Pharmaceuticals EPS (TTM) is -0.00.
From a Technical Analysis Perspective, Is 1AI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Algorae Pharmaceuticals Stock Split?
Algorae Pharmaceuticals has split 2 times.
How Many Employees Does Algorae Pharmaceuticals Have?
Algorae Pharmaceuticals has 48 employees.
What is the current trading status of Algorae Pharmaceuticals (1AI)?
As of 10 Oct 2025, Algorae Pharmaceuticals (1AI) is trading at a price of 0.009, with a previous close of 0.01. The stock has fluctuated within a day range of 0.009 to 0.011, while its 52-week range spans from 0.005 to 0.011.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.